South San Francisco, CA, United States of America

Chenggang Lu

USPTO Granted Patents = 3 

Average Co-Inventor Count = 9.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Chenggang Lu: Innovator in Therapeutic Solutions

Introduction

Chenggang Lu is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of therapeutic innovations, holding a total of 3 patents. His work focuses on developing novel solutions for various diseases, showcasing his commitment to advancing medical science.

Latest Patents

Chenggang Lu's latest patents include groundbreaking inventions such as Wnt surrogate molecules and uses thereof. This invention provides Wnt pathway agonists and related compositions, which may be utilized in a variety of therapeutic methods for treating diseases. Another notable patent is for anti-frizzled antibodies and methods of use. This invention offers anti-Fzd monoclonal antibodies and related compositions, which can also be applied in various therapeutic methods for disease treatment.

Career Highlights

Chenggang Lu is currently associated with Surrozen Operating, Inc., where he continues to innovate and contribute to the field of therapeutics. His work at Surrozen highlights his dedication to developing effective treatments that can improve patient outcomes.

Collaborations

Chenggang Lu collaborates with talented individuals such as Yang Li and Tom Zhiye Yuan. These partnerships enhance the innovative potential of his projects and contribute to the success of their collective efforts.

Conclusion

Chenggang Lu stands out as a key figure in the realm of therapeutic innovations, with a focus on developing solutions that address critical health challenges. His patents and collaborations reflect his commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…